CLEVELAND LEUKEMIA THERAPEUTICS, LLC

Basic Information

11000 CEDAR AVE
CLEVELAND, OH, 44106-3069

Company Profile

n/a

Additional Details

Field Value
DUNS: 827446381
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. TAS::75 0849::TAS TOPIC 255 DEVELOPMENT OF A TARGETED THERAPY FOR ACUTE MYELOID

    Amount: $199,833.00

    Acute myeloid leukemia (AML) is one of the most common forms of leukemia in adults and despite advances in treatment the 5 year survival is less than 20-50% in adults and significantly lower in the e ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening

    Amount: $188,748.00

    DESCRIPTION (provided by applicant): Loss of the p53 signaling pathway, either by mutation or loss of upstream or downstream signaling components, occurs in the vast majority of human cancers. In norm ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. A novel ellipticine analog as a therapeutic candidate for acute myeloid leukemia

    Amount: $153,770.00

    DESCRIPTION (provided by applicant): Existing therapeutic agents for Acute Myeloid Leukemia (AML) are inadequate to due poor efficacy and severe side effects. This is especially a problem in adults wh ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government